Medgiedra, UAB - financials and debts

Company age: 25 y. 0 mo.

Update

Medgiedra - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 737,096 628,263 624,687 656,666 729,808 698,799 636,442 657,971
Profit before tax 71,066 23,626 55,762 59,942 109,970 125,197 84,288 96,498
Net profit 60,801 18,090 47,787 50,878 93,365 106,522 71,827 81,055
Equity 669,136 661,669 689,468 740,347 833,711 920,233 932,060 953,114
Liabilities 106,097 64,534 76,167 72,230 86,042 94,217 105,682 116,598
Non-current assets 85,982 58,026 35,553 13,726 5,403 5,943 4,365 3,380
Current assets 689,251 668,177 730,082 798,851 913,319 1,008,187 1,033,377 1,066,332
Total assets 775,233 726,203 765,635 812,577 918,722 1,014,130 1,037,742 1,069,712
Taxes paid
STI taxes - - - - - 160,273 148,215 151,574
Social insurance contributions - - - - - 5,498 17,498 19,389
Financial indicators
Revenue change y/y +8.5% -14.8% -0.6% +5.1% +11.1% -4.2% -8.9% +3.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 7.8% 2.5% 6.2% 6.3% 10.2% 10.5% 6.9% 7.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 9.1% 2.7% 6.9% 6.9% 11.2% 11.6% 7.7% 8.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.2% 2.9% 7.6% 7.7% 12.8% 15.2% 11.3% 12.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 9.6% 3.8% 8.9% 9.1% 15.1% 17.9% 13.2% 14.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 94,098 83,768 102,689 109,444 148,435 174,700 159,111 151,841

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Medgiedra - Social security debts

From To Debt, €
2026-05-03 2026-05-07 0.01
2026-04-20 2026-04-29 0.01
2026-02-18 2026-02-22 0.06
2026-01-21 2026-02-05 0.06
2025-11-18 2025-11-20 55.93
2022-06-16 2022-07-12 0.01

Medgiedra - VMI tax arrears

From To Overdue, €
2026-04-17 2026-04-20 41.99
2026-04-14 2026-04-16 41.84
2024-12-19 2024-12-20 4668.95

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Medgiedra, UAB (code 135807054) is a private limited liability company engaged in wholesale of other intermediate products, except of paper rolls and paperboard. In the latest financial year, 2025, the company generated revenue of €658.0K and net profit of €81.1K, with a profit margin of 12.3%. Revenue increased by 3.4% year on year, after a decline from €698.8K in 2023 to €636.4K in 2024. Net profit followed a similar path, easing from €106.5K in 2023 to €71.8K in 2024, before recovering in 2025. Balance sheet structure remained strong, with total assets of €1.07M, equity of €953.1K and liabilities of €116.6K at year-end 2025. The equity ratio stood at 89.1% and debt to equity at 0.12, indicating limited leverage. Return on equity was 8.5% and return on assets 7.6%. Asset turnover was 0.62x. Revenue per employee reached €164.5K and profit per employee €20.3K, reflecting solid productivity in 2025.